KRAS and colorectal carcinoma: In summary, the data obtained through LC-MS-based global metabolomics, targeted metabolomics and kinetic isotope analysis indicated that SLC25A22 knockdown inhibited the biosynthesis of Asp-derived amino acids and polyamines in KRAS-mutant CRC cells.